Alumni News
Healthcare Alumni in the News
Columbia Business School alumni are accomplishing great things in healthcare. Please also visit our News page for additional features. Submit your alumni news to hpm@gsb.columbia.edu
Spring/Summer 2019
Robert Ang '05
Robert Ang '05 was appointed president and CEO of Vor Biopharma. In February, Vor raised $42 million in Series A financing to support development of a VOR33, a stem cell treatment in preclinical development for acute myeloid leukemia.
Roberta Lipson '78
United Family Healthcare (UHF), whose CEO is Roberta Lipson '78, will be acquired by New Frontier Corporation, to create one of China’s largest publicly listed integrated healthcare services companies.
Ian Laird '03
DaVita Health Solutions hired Ian Laird '03 as national vice president of growth.
Jessie Laurash '19
Health Enterprise Partners hired Jessie Laurash '19 as a senior associate.
Elizabeth Colonna '18
Health Enterprise Partners promotes Elizabeth Colonna '18 to vice president.
Susan Hertzberg '97
Susan Hertzberg '97 has joined BrainScope as its CEO. Previously she was CEO of Prelude Fertility.
Tarek Sherif '91
Tarek Sherif '91, CEO of Medidata Solutions, announced the sale of Medidata for $5.8 billion to to France's Dassault Systèmes.
Marco Scheller '95
Marco Scheller ’95 joined CareDx as Vice President. He was formerly with Ferring Pharmaceuticals.
Patrick Pilch '89
Patrick Pilch '89, Managing Director & National Healthcare Advisory Leader of BDO, writes about why more hospitals might follow Civica Rx's lead in distributing their own drugs and provides the new blueprint for how hospitals can innovate to generate alternative sources of revenue. Patrick is also a member HPM's Advisory Board.
Adriana Herrera '00
Adriana Herrera '00 has been appointed Senior Vice President of Americas Commercial Oncology at Eisai. Adriana is also a member HPM's Advisory Board.
Geraldine McGinty '00
Geraldine McGinty MD, MBA, FACR '00 is recognized as one of the Most Powerful Women in Healthcare IT in 2019 for her focus on the impact of AI on medical imaging and her expertise in imaging economics.
Beyhan Zaim '94
Beyhan Zaim '94, was appointed to Senior Vice President of Commercial Business Development (CBD) at Novo Nordisk. Beyhan is also a member of HPM's Advisory Board.
Ezra Mehlman '12
Ezra Mehlman '12, managing partner of Health Enterprise Partners, was quoted in Healthcare IT News discussing the recent sale of portfolio company InDemand Interpreting to Stratus Video. Ezra also co-teaches the popular Healthcare Investment and Entrepreneurship course at CBS
Isobel Rosenthal '18
Isobel Rosenthal '18 wins Grand Prize at this year's Psychiatry innovation Lab, APA's annual "shark tank"-style competition where entrepreneurs pitch their ideas on how to innovate and disrupt mental health care.
Roy Bejarano '04
Roy Bejarano '04, HPM's advisory board member and CEO & Co-Founder at Scale Physician Group, writes about U.S Healthcare in "Is what we Think We know About U.S. Healthcare Still Accurate Today?"
Sam Nelson '17
Sam Nelson '17, just joined Molina Healthcare (LinkedIn).
Manmeet Kaur '12
Manmeet Kaur, founder and CEO of City Health Works, was featured on Crain's 40 under 40 list for 2019.
Dan Brillman '12 and Talyor Justice '14
Dan Brillman and Taylor Justice, co-founders of Unite Us, raised $35M to connect healthcare with social services.
Jonathan Gordon '06
Jon Gordon was promoted to Managing Director of NYP Ventures, the venture arm of NewYork-Presbyterian.
Giovanni Monti '04
Giovanni Monti, Vice President and Director of Healthcare Innovation at Walgreens Boots Alliance, shared that Walgreens Find Care was recognized as an Honoree for The Webby Awards, considered the Internet’s most respected symbol of success, in the Health & Fitness category.
Fall 2018/Winter 2019
Roger Waltzman, MD '06
Dr. Roger Waltzman has been appointed Chief Medical Officer of Molecular Templates. Roger was previously CMO of Rgenix.
Roy Bejarano '04
Roy Bejarano launched Scale Physician Group to help physician practices scale to full-service platforms equipped to compete in the evolving healthcare landscape.
Rachel Stahler '07
Rachel Stahler has joined Allergan as Chief Information Officer. Rachel was previously at Syneos Health.
Emme Deland '80
Emme Deland Senior Vice President and Chief Strategy Officer at NewYork-Presbyterian, has defined the future of healthcare delivery with the goal to improve access to care.
Shoshanah Brown '04
Shoshanah Brown Chief Executive Officer of AIRnyc, works to bring home healthcare to underserved low-income New York City communities.
Dr. Joao Siffert '02
Joao Siffert, MD, was appointed CEO of Abeona Therapeutics.
Isobel Rosenthal '18
Isobel Rosenthal co-authored Behavioral Health Innovation Two Years Later: Why is Adoption Taking so Long? with Dr. Dan Gebremedhin, a partner at Flare Capital.
Ezra Mehlman '12
Ezra Mehlman has been promoted to Managing Partner at Health Enterprise Partners.
Daniel O’Day '97
Dan O'Day was named Chairman and CEO of Gilead Sciences, effective March 1, 2019. He is currently CEO of of Roche Pharmaceuticals.
Jeremy Miller '10
FSAStore.com, led by Jeremy Miller, was named one of the Best Places to Work by Crain's New York Business.
Rick Fair '92
Rick Fair, CEO of Bellicum Pharmaceuticals, was appointed to the Board of Directors of Clovis Oncology.
Patrick Pilch '89
Patrick Pilch, Managing Director & National Healthcare Advisory Leader at BDO, was honored by Irish America Magazine as one of 50 Healthcare and Life Sciences professionals who are changing the world.
Robert Jacks '01
Robert Jacks has become CEO of Indalo Therapeutics, which is backed by Atlas Venture and F-Prime Capital.
Karim Babay '01
Karim Babay '01, CEO of HealthSapiens, discusses The Global Healthcare Crisis in Electronic Health Reporter.
Dr. Mussaad M. Al-Razouki '07
Nabta Health, where Dr. Mussaad M. Al-Razouki is Executive Chairman and Co-Founder, won Best AI Startup and Best Overall Startup at the Accenture Innovation Cup as part of the GITEX Future Stars.
Roger Waltzman MD '06
Rgenix, where Dr. Roger Waltzman is Chief Medical Officer, has raised $40 million in series C financing to carry out early and midstage trials for a pair of cancer drugs: an immunotherapy for solid tumors and a cancer metabolism inhibitor for gastrointestinal cancers.
Laur Blumberg MD '98
Syntimmune, cofounded by Laur Blumberg, was acquired by Alexion for $400M for its drug for rare anemia.
Gail Boudreaux '89
Gail Boudreaux, CEO of Anthem, was named #5 on Fortune Magazine's 2018 Most Powerful Women list. "In the position for less than a year, she’s already put the $90-billion-in-revenue insurer on the right trajectory, with the stock up 45% year over year."
Tracy Bahl '04
Tracy Bahl has joined OneOncology as President and Chief Executive Officer.
Dr. Giovanni Colella '95
Giovanni Colella is founding CEO of OODA Health, which raised $40.5 Million to transform the U.S. healthcare payment system
Shahram Ebadollahi '16
Shahram Ebadollahi joined Novartis to head up Advanced Analytics.
Emme Deland '80
Emme Deland has been named to Crain’s New York's list of “Notable Women in Health Care,” the publication’s inaugural list honoring health care executives, researchers and clinicians who have profoundly impacted New York City through their professional, civic and philanthropic achievements.
Darren Campili '96
Darren Campili has become Vice Chairman, Healthcare Banking at Barclays.